Article metrics

Download PDFPDF

Original research
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: April 2020 to August 2020

AbstractFullPdf
Apr 2020728728403
May 2020742742385
Jun 2020284284104
Jul 2020320320153
Aug 202024024085
Total231423141130